SCHEMBL18079825

SCHEMBL18079825

CCN(CC)Cc1cccc2c1-c1ccccc1C21c2ccccc2-c2ccccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 1/20 0.42
▸ ADORA1 P30542 1/20 0.42
▸ PDK2 Q15119 3/20 0.42
▸ TSHR P16473 2/20 0.38
▸ MAPT P10636 3/20 0.36
▸ HSD17B10 Q99714 2/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ HPGD P15428 1/20 0.36
▸ CYP2D6 P10635 2/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ NFKB1 P19838 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ LMNA P02545 1/20 0.35
▸ BLM P54132 1/20 0.35
▸ MAOB P27338 2/20 0.34
▸ ICMT O60725 1/20 0.34
▸ CDK1 P06493 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18079822 0.98 PDK2 (0.43) ADORA2AADORA1PDK2TSHRMAPT
SCHEMBL18907590 0.91 ADORA2A (0.42) ADORA2AADORA1PDK2TSHRMAPT
SCHEMBL17854959 0.90 ADORA2A (0.43) ADORA2AADORA1PDK2TSHRMAPT
SCHEMBL18079829 0.85 ADORA2A (0.42) ADORA2AADORA1PDK2TSHRMAPT
SCHEMBL16544651 0.84 PDK2 (0.41) PDK2TSHRMAPTHSD17B10KDM4E
SCHEMBL16544649 0.82 PDK2 (0.42) PDK2TSHRMAPTHSD17B10KDM4E
SCHEMBL26884444 0.79 ADORA2A (0.38) ADORA2AADORA1TSHRMAPTHSD17B10
SCHEMBL26884428 0.79 ADORA2A (0.38) ADORA2AADORA1TSHRMAPTHSD17B10
SCHEMBL16544647 0.79 CYP1A2 (0.38) PDK2TSHRMAPTHSD17B10KDM4E
SCHEMBL19773285 0.77 PDK2 (0.41) PDK2TSHRMAPTKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230217818-A1 ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THEREOF LG DISPLAY CO., LTD. (KR) 2023-07-06 — — US disclosed
US-9896621-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2018-02-20 — — US disclosed
US-20170155050-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-01 — — US disclosed
US-20160260901-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2016-09-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230217818-A1 ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THEREOF OCIAD2, OCIAD1, DRD1 ADORA2A 2765/4885ADORA1 3974/4885PDK2 2046/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback